Assembly Biosciences Inc ASMB:NASDAQ

RT Quote | USD
Last | 05/14/24 EDT
13.90UNCH (UNCH)
Volume
105
52 week range
7.69 - 20.04
Loading...
  • Open14.04
  • Day High14.04
  • Day Low14.04
  • Prev Close13.90
  • 52 Week High20.04
  • 52 Week High Date10/17/23
  • 52 Week Low7.69
  • 52 Week Low Date11/22/23

Key Stats

  • Market Cap76.635M
  • Shares Out5.51M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta0.61
  • YTD % Change41.24

KEY STATS

  • Open14.04
  • Day High14.04
  • Day Low14.04
  • Prev Close13.90
  • 52 Week High20.04
  • 52 Week High Date10/17/23
  • 52 Week Low7.69
  • 52 Week Low Date11/22/23
  • Market Cap76.635M
  • Shares Out5.51M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta0.61
  • YTD % Change41.24

RATIOS/PROFITABILITY

  • EPS (TTM)-11.23
  • P/E (TTM)-1.24
  • Fwd P/E (NTM)-29.57
  • EBITDA (TTM)-55.458M
  • ROE (TTM)-99.78%
  • Revenue (TTM)12.948M
  • Gross Margin (TTM)-
  • Net Margin (TTM)-396.62%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Assembly Biosciences Inc

 

Profile

MORE
Assembly Biosciences, Inc. is a biotechnology company, which is engaged in the development of small molecule antiviral therapeutics. The Company’s pipeline includes two helicase-primase inhibitors (HPI) targeting recurrent genital herpes, an orally bioavailable hepatitis delta virus (HDV) entry inhibitor, a clinical-stage capsid assembly modulator (CAM) designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points with the aim of achieving finite...
William Ringo Jr.
Non-Executive Independent Chairman of the Board
Jason Okazaki
President, Chief Executive Officer, Director
Address
Two Tower Place, 7Th Floor
South San Francisco, CA
94080
United States

Top Peers

SYMBOLLASTCHG%CHG
ALGS
Aligos Therapeutics Inc
0.6915UNCHUNCH
CARM
Carisma Therapeutics Inc
1.50+0.04+2.74%
JAGX
Jaguar Health Inc
0.2772+0.0023+0.8367%
GRTS
Gritstone bio Inc
0.7607-0.0006-0.0788%
KRON
Kronos Bio Inc
1.01+0.01+1.05%